Although studies on coronary perfusion with DPP4i are lacking, there are some clinical studies that suggest DPP4 inhibition may improve coronary flow reserve and myocardial perfusion reserve in patients with diabetes and CAD (Kato et al., 2016; Oh et al., 2021). This evidence concerns the gene DPP4 and coronary artery disorder.